- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01155622
Trial of Different Hypothermia Temperatures in Patients Recovered From Out-of-hospital Cardiac Arrest
December 4, 2012 updated by: Esteban Lopez de Sa Areses, Hospital Universitario La Paz
Pilot Randomized Clinical Trial Comparing the Efficacy of Two Different Hypothermia Temperatures for Treatment of Comatose Patients Recovered From an Out-of-hospital Cardiac Arrest
Mild therapeutic hypothermia in the temperature range of 32º - 34ºC.
improves survival in patients recovered from a ventricular fibrillation cardiac arrest.
The same therapy is suggested with less evidence for asystole as first rhythm after cardiac arrest.
The purpose of this study is to determine whether different temperature targets (32º vs 34º) may have different efficacy in the treatment of post-cardiac arrest patients.
If successful, this pilot study will eventually form the basis for a larger, multicentric randomized clinical trial.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patients admitted consecutively were potentially eligible for the study if they had a witnessed out-off hospital cardiac arrest (OHCA) apparently related to heart disease and an interval of <60 minutes from collapse to return of spontaneous circulation (ROSC). Additional inclusion criteria were:
- Age >18 years.
- Initial registered rhythm of a shockable rhythm (ventricular fibrillation or pulseless ventricular tachycardia) or asystole.
Exclusion criteria were:
- Known pregnancy
- Glasgow Coma Scale score after ROSC >8.
- Cardiogenic shock (a systolic blood pressure of <80 mm Hg despite inotrope infusion >30 minutes).
- Other nonshockable rhythms (pulseless electric activity).
- Terminal illness present before the OHCA.
- Possible causes of coma other than cardiac arrest (drug overdose, head trauma, or cerebrovascular accident).
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Madrid, Spain, 28046
- Intensive Cardiac Care Unit. Hospital Universitario la Paz
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age > 18
- Resuscitated patients from a cardiac arrest with first rhythm of ventricular fibrillation or asystole
- Witnessed cardiac arrest
- Estimated delay between cardiac arrest and advanced resuscitation < 20 min.
- Resuscitation time from first contact to recovery of spontaneous circulation < 60 min.
- Hemodynamic stability (Mean blood pressure [BP] >60 mmHg), with or without inotropic drugs, before randomization
- Glasgow coma score <9 without sedation before randomization
Exclusion Criteria:
- Pregnant women or suspected pregnancy or fertile women without a negative pregnancy test
- Suspected non-cardiac arrest caused coma
- Electrical instability (uncontrollable life-threatening arrhythmias)
- Hemodynamic instability (Mean BP ≤60 mmHg), refractory to volume infusion or inotropic drugs
- Refractory hypoxemia (saturation <85% with FiO2=100%)
- Previous known terminal illness
- Active bleeding or known coagulopathy
- Opposition from patient's family to enter the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 32º Celsius
Endovascular Cooling was set at a target temperature of 32°C
|
Infusion of <8°C cold saline followed by the implantation of the Icy 9.3F 38-cm catheter (ZOLL Medical Corporation, Chelmsford, MA) placed in the inferior vena cava through a femoral vein connected to the Thermogard XP Temperature Management System (ZOLL Medical Corporation).
Cooling was set at a maximum rate with a target temperature of 32°C or 34°C according to randomization.
|
Active Comparator: 34º Celsius
Endovascular Cooling was set at a target temperature of 32°C
|
Infusion of <8°C cold saline followed by the implantation of the Icy 9.3F 38-cm catheter (ZOLL Medical Corporation, Chelmsford, MA) placed in the inferior vena cava through a femoral vein connected to the Thermogard XP Temperature Management System (ZOLL Medical Corporation).
Cooling was set at a maximum rate with a target temperature of 32°C or 34°C according to randomization.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Survival free from severe dependence (Barthel index <60)
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Survival at 6 months
Time Frame: 6 months
|
6 months
|
|
Barthel Index at 6 months
Time Frame: 6 months
|
6 months
|
|
Life threatening arrhythmias in different hypothermia temperatures
Time Frame: 48 hours (during hypothermia)
|
New life-threatening arrhythmias during hypothermia: ventricular fibrillation, sustained (>30 sec.)
monomorphic or polymorphic ventricular tachycardia, extreme bradycardia (heart rate <35 bpm.
and/or pauses >3 sec.)
|
48 hours (during hypothermia)
|
Impact on ventricular function of different hypothermia temperatures
Time Frame: 48 hours During hypothermia
|
Echocardiographic evaluation of possible impact of different hypothermia temperatures on ventricular diastolic and systolic function
|
48 hours During hypothermia
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Esteban Lopez-de-Sa, MD, FESC, Intensive Cardiac Care Unit. Department of Cardiology. Hospital Universitario La Paz
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2008
Primary Completion (Actual)
April 1, 2012
Study Completion (Actual)
May 1, 2012
Study Registration Dates
First Submitted
July 1, 2010
First Submitted That Met QC Criteria
July 1, 2010
First Posted (Estimate)
July 2, 2010
Study Record Updates
Last Update Posted (Estimate)
December 5, 2012
Last Update Submitted That Met QC Criteria
December 4, 2012
Last Verified
December 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Hypothermia_32vs34
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Arrest
-
Australian and New Zealand Intensive Care Research...Ambulance VictoriaNot yet recruitingOut of Hospital Cardiac Arrest
-
University Medical Centre MariborRecruiting
-
IRCCS Policlinico S. MatteoOslo University Hospital; University of the Basque Country (UPV/EHU); The Hospital...CompletedOut-Of-Hospital Cardiac ArrestItaly, Norway, Spain
-
Lithuanian University of Health SciencesEgle Vaitkaitiene; Dinas Vaitkaitis; Asta Krikscionaitiene; Ilona Kajokaite; Nerijus...CompletedOut-Of-Hospital Cardiac ArrestLithuania
-
Ceric SàrlAbbottTerminatedOut of Hospital Cardiac ArrestBelgium, France, Serbia
-
Prehospital Center, Region ZealandCompletedOut-Of-Hospital Cardiac Arrest
-
Karolinska InstitutetSwedish Heart Lung FoundationCompletedCardiac Arrest | Out of Hospital Cardiac ArrestSweden
-
Karolinska InstitutetVastra Gotaland Region; SOS Alarm Sverige AB; Everdrone AB; Aviation capacity resources... and other collaboratorsCompleted
-
Brno University HospitalTerminatedOut-Of-Hospital Cardiac ArrestCzechia
-
SRINIVAS RAMAKAUnknownOut-Of-Hospital Cardiac ArrestIndia
Clinical Trials on Endovascular Cooling
-
S. Andrea HospitalCompletedStroke | Carotid Artery Plaque | Carotid Artery Diseases | Hypothermia | Cerebrovascular Accident | Carotid Artery StenosisItaly
-
ZOLL Circulation, Inc., USAPhilips Healthcare; Lund University HospitalCompletedAcute Anterior Myocardial InfarctionSweden
-
Bispebjerg HospitalMalmö UniversityCompletedCerebral InfarctionDenmark
-
State University of New York at BuffaloCompleted
-
University of Mississippi Medical CenterNot yet recruiting
-
Second Affiliated Hospital, School of Medicine,...Jinhua People's Hospital; Jinhua Municipal Central Hospital; Yiwu Central Hospital and other collaboratorsRecruiting
-
VA Office of Research and DevelopmentNot yet recruitingSpinal Cord InjuriesUnited States
-
The Cleveland ClinicCompleted
-
Indonesia UniversityCompletedHeart; Surgery, Heart, Functional Disturbance as ResultIndonesia
-
Robertson, Nicola, M.D.Thayyil, SudhinUnknown